• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交感性眼炎中的黑色素瘤特异性Th1细胞毒性T淋巴细胞系

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

作者信息

Norose K, Yano A

机构信息

Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Br J Ophthalmol. 1996 Nov;80(11):1002-8. doi: 10.1136/bjo.80.11.1002.

DOI:10.1136/bjo.80.11.1002
PMID:8976730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC505680/
Abstract

AIMS/BACKGROUND: To determine the functional properties and cytokine production profiles of melanoma specific cytotoxic T lymphocytes (CTLs) induced from peripheral blood leucocytes of two patients with Vogt-Koyanagi-Harada disease (VKH).

METHODS

Melanoma specific CTL lines were established by long term coculture with a human melanoma cell line (P-36). Cytotoxic activity against P-36 was measured by 51Cr release. The involvement of human leucocyte antigen (HLA) class I or class II molecules in the cytotoxicity of the CTL lines against P-36 was analysed using anti-HLA class I or anti-HLA class II monoclonal antibody (MAb). Surface molecules of CTL lines were analysed by flow cytometry using MAbs specific for CD4, CD8, CD16, CD25, CD56, HLA-DR, T cell antigen receptor (TCR) alpha beta and TCR gamma delta. Cytokine production and soluble interleukin 2 receptor (sIL-2R) secretion were determined by enzyme linked immunosorbent assays. mRNAs of cytokines were analysed using reverse transcription polymerase chain reaction (RT-PCR).

RESULTS

CTLs showed strong cytotoxic activity against P-36. The CTL activity of the cell lines against P-36 was inhibited by the anti-HLA-DR MAb, whereas the MAb specific for monomorphic determinants of HLA-A, B, and C failed to block lytic activity. Flow cytometry identified the following surface molecules: CD4+, CD8-, CD16-, CD25+, CD56-, HLA-DR+, TCR alpha beta +, and TCR gamma delta-. CTLs constitutively produced a high level of IL-6. IL-6 production and sIL-2R secretion of CTLs were enhanced when CTLs were stimulated with P-36. CTLs also produced high levels of interferon gamma (IFN-gamma) and IL-2, but not IL-4. mRNAs of IL-2 and IFN-gamma were detected by RT-PCR in the CTLs.

CONCLUSIONS

Melanoma specific HLADR restricted T helper 1 (Th1) CTLs may play a role in the immunopathogenesis of VKH.

摘要

目的/背景:确定从两名葡萄膜大脑炎(VKH)患者外周血白细胞诱导产生的黑色素瘤特异性细胞毒性T淋巴细胞(CTL)的功能特性和细胞因子产生谱。

方法

通过与人黑色素瘤细胞系(P-36)长期共培养建立黑色素瘤特异性CTL系。采用51Cr释放法测定对P-36的细胞毒性活性。使用抗I类或抗II类人白细胞抗原(HLA)单克隆抗体(MAb)分析HLA I类或II类分子在CTL系对P-36细胞毒性中的作用。使用针对CD4、CD8、CD16、CD25、CD56、HLA-DR、T细胞抗原受体(TCR)αβ和TCRγδ的MAb通过流式细胞术分析CTL系的表面分子。通过酶联免疫吸附测定法测定细胞因子产生和可溶性白细胞介素2受体(sIL-2R)分泌。使用逆转录聚合酶链反应(RT-PCR)分析细胞因子的mRNA。

结果

CTL对P-36表现出强烈的细胞毒性活性。抗HLA-DR MAb可抑制细胞系对P-36的CTL活性,而针对HLA-A、B和C单态性决定簇的MAb未能阻断裂解活性。流式细胞术鉴定出以下表面分子:CD4+、CD8-、CD16-、CD25+、CD56-、HLA-DR+、TCRαβ+和TCRγδ-。CTL组成性地产生高水平的IL-6。当用P-36刺激CTL时,CTL的IL-6产生和sIL-2R分泌增强。CTL还产生高水平的干扰素γ(IFN-γ)和IL-2,但不产生IL-4。通过RT-PCR在CTL中检测到IL-2和IFN-γ的mRNA。

结论

黑色素瘤特异性HLA-DR限制性T辅助1(Th1)CTL可能在VKH的免疫发病机制中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8da/505680/ab6cef3ee73c/brjopthal00011-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8da/505680/ab6cef3ee73c/brjopthal00011-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8da/505680/ab6cef3ee73c/brjopthal00011-0074-a.jpg

相似文献

1
Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.交感性眼炎中的黑色素瘤特异性Th1细胞毒性T淋巴细胞系
Br J Ophthalmol. 1996 Nov;80(11):1002-8. doi: 10.1136/bjo.80.11.1002.
2
T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.HLA-DRB1*0405阳性和阴性伏格特-小柳-原田葡萄膜炎患者中黑素细胞表位诱导的T细胞识别和细胞因子谱
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2465-71. doi: 10.1167/iovs.04-1273.
3
Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.交感性眼炎中的细胞因子产生与辅助性T细胞亚群
Curr Eye Res. 2001 Apr;22(4):312-8. doi: 10.1076/ceyr.22.4.312.5510.
4
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.葡萄膜大脑炎患者的眼部浸润性CD4 + T细胞可识别人类黑素细胞抗原。
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2547-54. doi: 10.1167/iovs.05-1547.
5
Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.黑色素瘤特异性细胞毒性CD4(+)辅助性T细胞2的产生:黑色素瘤上的HLA - DR15和Fas抗原对其被Th2细胞裂解均有需求。
Cell Immunol. 2001 Jun 15;210(2):96-105. doi: 10.1006/cimm.2001.1809.
6
Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病中T细胞亚群、可溶性白细胞介素-2受体及白细胞介素-6的特征分析
Jpn J Ophthalmol. 1992;36(1):37-43.
7
Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.从日本转移性黑色素瘤患者中鉴定黑色素瘤相关肽特异性CTL系的新方法。
Int J Oncol. 2008 Sep;33(3):433-41.
8
Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.与Vogt-小柳-原田综合征活动性葡萄膜炎相关的CD4+CD25高调节性T细胞频率和功能降低。
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3475-82. doi: 10.1167/iovs.08-1793. Epub 2008 Apr 17.
9
Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.针对弓形虫感染的人黑色素瘤细胞产生干扰素-γ的CD4+细胞毒性T淋巴细胞的细胞毒性增强。
J Immunol. 1995 Jan 1;154(1):290-8.
10
Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.人类肠道中的上皮内淋巴细胞具有溶解潜能和细胞因子谱,提示其具有辅助性T细胞1型和细胞毒性功能。
J Immunol. 1996 Sep 1;157(5):1926-34.

引用本文的文献

1
Steroid pulse therapy for VKH during pregnancy: a safe and effective option?孕期VKH的类固醇脉冲疗法:一种安全有效的选择?
Orphanet J Rare Dis. 2025 Jul 16;20(1):366. doi: 10.1186/s13023-025-03916-9.
2
Unilateral choroidal detachment in an elderly patient with Vogt-Koyanagi-Harada disease: a case report and literature review.老年Vogt-小柳-原田病患者单侧脉络膜脱离:病例报告及文献复习
Front Immunol. 2025 Feb 27;16:1514306. doi: 10.3389/fimmu.2025.1514306. eCollection 2025.
3
Categories and Profiles of Uveitis in Vogt-Koyanagi-Harada Syndrome With Systemic Correlation: Inferences From a Tertiary Multispecialty Hospital.

本文引用的文献

1
Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.白细胞介素6和干扰素γ对弓形虫感染的黑色素瘤细胞中HLA-DR表达及抗原呈递的差异调节
Microbiol Immunol. 1996;40(6):443-9. doi: 10.1111/j.1348-0421.1996.tb01091.x.
2
Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.针对弓形虫感染的人黑色素瘤细胞产生干扰素-γ的CD4+细胞毒性T淋巴细胞的细胞毒性增强。
J Immunol. 1995 Jan 1;154(1):290-8.
3
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
伴全身相关性的葡萄膜炎在小柳原田综合征中的分类及特征:来自一家三级多专科医院的推断
Cureus. 2024 Jul 20;16(7):e64998. doi: 10.7759/cureus.64998. eCollection 2024 Jul.
4
Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery.COVID-19 mRNA疫苗接种后发生的葡萄膜炎性青光眼-小柳原田综合征:与Th2向Th1转变相关的分子机制
Acta Derm Venereol. 2024 May 13;104:adv21502. doi: 10.2340/actadv.v104.21502.
5
Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases.活性免疫介导性眼内炎症性疾病患者中晚期糖基化终产物与葡萄膜炎/巩膜炎活动之间的关系。
Int Ophthalmol. 2024 Feb 8;44(1):33. doi: 10.1007/s10792-024-02980-7.
6
Vogt-Koyanagi-Harada Disease and COVID.伏格特-小柳-原田病与新冠病毒
J Clin Med. 2023 Sep 27;12(19):6242. doi: 10.3390/jcm12196242.
7
Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.未接受静脉注射甲泼尼龙治疗的患者中,纳武单抗诱导的类葡萄膜大脑炎样葡萄膜炎的结局
Case Rep Ophthalmol Med. 2023 Feb 8;2023:9565205. doi: 10.1155/2023/9565205. eCollection 2023.
8
Ocular Inflammation Induced by Immune Checkpoint Inhibitors.免疫检查点抑制剂引起的眼部炎症。
J Clin Med. 2022 Aug 25;11(17):4993. doi: 10.3390/jcm11174993.
9
Tubercular Harada disease - An unreported uveitic entity.结核性原田病——一种未被报道的葡萄膜炎类型。
Ann Med Surg (Lond). 2022 Jul 31;80:104294. doi: 10.1016/j.amsu.2022.104294. eCollection 2022 Aug.
10
Identification of immune hub genes participating in the pathogenesis and progression of Vogt-Koyanagi-Harada disease.鉴定参与 Vogt-Koyanagi-Harada 病发病机制和进展的免疫枢纽基因。
Front Immunol. 2022 Jul 25;13:936707. doi: 10.3389/fimmu.2022.936707. eCollection 2022.
通过细胞因子谱鉴定出的针对自体人黑色素瘤的多个CD4+和CD8+细胞毒性T细胞克隆亚群。
Int J Cancer. 1994 Apr 1;57(1):56-62. doi: 10.1002/ijc.2910570111.
4
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.被I类限制性肿瘤浸润性T淋巴细胞识别的人类黑色素瘤肽的鉴定
J Immunol. 1993 Oct 1;151(7):3719-27.
5
Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis.内源性与外源性葡萄膜炎患者房水中活化T淋巴细胞的双色流式细胞术分析
Curr Eye Res. 1995 Jun;14(6):425-33. doi: 10.3109/02713689509003752.
6
Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.抗原呈递T细胞诱导细胞毒性CD4+ T细胞的发育。I. CD80-CD28黏附分子的作用。
J Immunol. 1995 Jul 1;155(1):118-27.
7
Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.干扰素α和γ对人葡萄膜黑色素瘤细胞的体外作用。
Br J Ophthalmol. 1995 Sep;79(9):847-55. doi: 10.1136/bjo.79.9.847.
8
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.黑色素细胞和黑色素瘤的表面抗原。黑色素细胞分化标志物和黑色素瘤亚群。
J Exp Med. 1982 Dec 1;156(6):1755-66. doi: 10.1084/jem.156.6.1755.
9
Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells.由培养的淋巴细胞的细胞毒性和增殖反应所定义的人类肿瘤抗原。
Nature. 1982 Mar 25;296(5855):359-61. doi: 10.1038/296359a0.
10
Long-term growth and cloning of non-transformed lymphocytes.未转化淋巴细胞的长期生长与克隆
Nature. 1981 Dec 24;294(5843):697-9. doi: 10.1038/294697a0.